News & Updates

Show Multimedia Only
Donanemab delays Alzheimer's disease progression over 3 years
Donanemab delays Alzheimer's disease progression over 3 years
04 Jun 2026 byKanas Chan

Donanemab administered for a limited duration continues to slow clinical progression in patients with early symptomatic Alzheimer’s disease (AD) over 3 years, according to Professor Chaur-Jong Hu of the Department of Neurology, Taipei Medical University, who spoke at Advances in Medicine (AIM) 2026. 

Donanemab delays Alzheimer's disease progression over 3 years
04 Jun 2026
Malnutrition prevalence in older adults stresses need for early nutritional intervention
Malnutrition prevalence in older adults stresses need for early nutritional intervention
03 Jun 2026
Blood test detects signs of Alzheimer’s disease in midlife
Blood test detects signs of Alzheimer’s disease in midlife
02 Jun 2026
Diet, exercise help improve erectile function
Diet, exercise help improve erectile function
29 May 2026 byStephen Padilla

Adult men with erectile dysfunction may benefit from diet- and exercise-based interventions, which in a recent study have shown to yield modest but significant improvements in erectile function.

Diet, exercise help improve erectile function
29 May 2026